Postoperative oral amiodarone as prophylaxis against atrial fibrillation after coronary artery surgery

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 16, Issue 5, 2002, Pages 603-606

  Yazigi, Alexandre ^a   Rahbani, Pielly ^a   Zeid, Hicham Abou ^a   Madi Jebara, Samia ^a   Haddad, Fadia ^a   Hayek, Gemma ^a  

^a SAINT JOSEPH UNIVERSITY   (Lebanon)

Author keywords

Amiodarone; Antiarrhythmic drugs; Atrial fibrillation (AF); Coronary artery surgery; Oral

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; ATRIOVENTRICULAR BLOCK; BRADYCARDIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY SURGERY; DOSE RESPONSE; DRUG INDUCED DISEASE; DRUG SAFETY; FEMALE; HEART ATRIUM FIBRILLATION; HEART VENTRICLE; HOSPITAL DISCHARGE; HUMAN; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL DISEASE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0036795376     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/jcan.2002.126956     Document Type: Article

References (25)

1. Butler J, Harriss DR, Sinclair M, Westaby S: Amiodarone prophylaxis for tachycardias after coronary artery surgery: A randomised, double-blind, placebo-controlled trial. Br Heart J 70:56-60, 1993
2. Hashimoto K, Ilstrup DM, Schaff HV: Influence of clinical and hemodynamic variables on risk of supraventricular tachycardia after coronary artery bypass. J Thorac Cardiovasc Surg 101:56-65, 1991
3. Leitch JW, Thomson D, Baird DK, Harris PJ: The importance of age as a predictor of atrial fibrillation and flutter after coronary artery bypass grafting. J Thorac Cardiovasc Surg 100:338-342, 1990
4. Rubin DA, Nieminski KE, Reed GE, Herman MV: Predictors, prevention and long-term prognosis of atrial fibrillation after coronary artery bypass graft operations. J Thorac Cardiovasc Surg 94:331-335, 1987
5. Creswell LL, Schuessler RB, Rosenbloom M, Cox JM: Hazards of postoperative atrial arrhythmias. Ann Thorac Surg 56:539-549 1993
6. Davison R, Hartz R, Kaplan K, et al: Prophylaxis of supraventricular tachyarrhythmia after coronary bypass surgery with oral verapamil: A randomised, double-blind trial. Ann Thorac Surg 39:336-339, 1985
7. Kowey PR, Taylor JE, Rials SJ, Marinchak RA: Meta-analysis of the effectiveness of prophylactic drug therapy in preventing supraventricular arrhythmia early after coronary artery bypass grafting. Am J Cardiol 69:963-965, 1992
8. England MR, Gordon G, Salem M, Chernow B: Magnesium administration and dysrhythmias after cardiac surgery: A placebo-controlled, double-blind, randomized trial, JAMA 268:2395-2402, 1992
9. Aranki SF, Shaw DP, Adams DH, et al: Predictors of atrial fibrillation after coronary artery surgery: Current trends and impact on hospital resources. Circulation 94:390-397, 1996
10. Middlekauff HR, Wiener I, Stevenson WG: Low-dose amiodarone for atrial fibrillation. Am J Cardiol 72:75F-81F, 1993
11. Gosselink AT, Crijns HJ, Van Gelder IC, et al: Low-dose amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation or flutter. JAMA 267:3289-3293, 1992
12. Roy D, Talajic M, Dorian P, et al: Amiodarone to prevent reccurence of atrial fibrillation. N Engl J Med 342:913-920, 2000
13. Nicklas JM, McKenna WJ, Stewart RA, et al: Prospective, double-blind, placebo-controlled trial of low-dose amiodarone in patients with severe heart failure and asymptomatic frequent ventricular ectopy. Am Heart J 122:1016-1021, 1991
14. Daoud EG, Strickberger SA, Man KC, et al: Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery. N Engl J Med 337:1785-1791, 1997
15. Redle JD, Khurana S, Marzan R, et al: Prophylactic oral amiodarone compared with placebo for prevention of atrial fibrillation after coronary artery bypass surgery. Am Heart J 138:144-150, 1999
16. Giri S, White M, Dunn AB, et al: Oral amiodarone for prevention of atrial fibrillation after open heart surgery, the atrial fibrillation suppression trial (AFIST): A randomized placebo-controlled trial. Lancet 357:830-836, 2001
17. Katariya K, DeMarchena E, Bolooki H: Oral amiodarone reduces incidence of postoperative atrial fibrillation. Ann Thorac Surg 68:1599-1604, 1999
18. Singh BN, Vaughan Williams EM: The effect of amiodarone, a new anti-anginal drug, on cardiac muscle. Br J Pharmacol 39:657-667, 1970
19. Côté P, Bourassa MG, Delaye J, et al: Effects of amiodarone on cardiac and coronary hemodynamics and on myocardial metabolism in patients with coronary artery disease. Circulation 59:1165-1172, 1979
20. , Treggiari-Venzi MM, Waeber JL, Perneger TV, et al: Intravenous amiodarone or magnesium sulfate is not cost-beneficial prophylaxis for atrial fibrillation after coronary artery bypass surgery. Br J Anaesth 85:690-695, 2000
21. Guarnieri T, Nolan S, Gottlieb SO, et al: Intravenous amiodarone for the prevention of atrial fibrillation after open heart surgery: The Amiodarone Reduction in Coronary Heart (ARCH) trial. J Am Coll Cardiol 34:343-347, 1999
22. Frost L, Molgaard H, Christiansen EH, et al: Low vagal tone and supraventricular ectopic activity predict atrial fibrillation and flutter after coronary artery bypass grafting. Eur Heart J 16:825-831, 1995
23. , Greenspon AJ, Kidwell GA, Hurley W, Mannion J: Amiodarone-related postoperative adult respiratory distress syndrome, Circulation 84:407-415, 1991 (suppl III)
24. Van Mieghem W, Coolen L, Malysse I, et al: Amiodarone and the development of ARDS after lung surgery. Chest 105:1642-1645, 1994
25. Sideris DA, Toumanidis ST, Tselepatiotis E, et al: Atrial pressure and experimental atrial fibrillation. Pacing Clin Electrophysiol 18:1679-1685, 1995